Immunologic intervention in the pathogenesis of osteoarthritis

Arthritis and Rheumatism

Volumn 48, Issue 3, 2003, Pages 602-611

  Yuan, Guo Hua ^a   Masuko Hongo, Kayo ^a   Kato, Tomohiro ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AUTOANTIGEN; COLLAGEN; CYTOKINE; ICOSANOID;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CARTILAGE CELL; CELL FUNCTION; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOGENICITY; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SYNOVIUM;

CARTILAGE, ARTICULAR; CHONDROCYTES; HUMANS; IMMUNOTHERAPY; OSTEOARTHRITIS; SYNOVITIS;

EID: 0037333852     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10768     Document Type: Review

References (121)

1. Peyron J. Inflammation of osteoarthritis (OA): review of its role in clinical picture, disease progress, subsets and pathophysiology. Semin Arthritis Rheum 1980;11 Suppl 1:115-6.
2. Pelletier J-P, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237-47.
3. Goldberg VM, Kresina TF. Immunology of articular cartilage. J Rheumatol 1987;14:73-6.
4. Goldberg DL, Egan MS, Cohen AS. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982;9:204-9.
5. Haraoui B, Pelletier J-P, Cloutier J-M, Faure M-P, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis: in vivo effects of antirheumatic drugs. Arthritis Rheum 1991;34:153-63.
6. Kennedy TD, Plater-Zyberk C, Partridge TA, Woodrow DF, Maini RN. Morphometric comparison of synovium from patients with osteoarthritis and rheumatoid arthritis. J Clin Pathol 1988; 41:847-52.
7. Lindblad S, Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987;30:1081-8.
8. Poole AR. Immunology of cartilage. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, editors. Osteoarthritis: diagnosis and medical/surgical management. 2nd ed. Philadelphia: WB Saunders; 1992. p. 155-89.
9. Banerjee S, Poole AR. Immunity to cartilage proteoglycans. J Rheumatol Suppl 1992;33:36-9.
10. Eyre DR, Wu JJ. Collagen structure and cartilage matrix integrity. J Rheumatol Suppl 1995;43:82-5.
11. Gregory AE, Keene DR, Tufa SF, Lunstrum GP, Morris NP. Developmental distribution of collagen type XII in cartilage: association with articular cartilage and the growth plate. J Bone Miner Res 2001;16:2005-16.
12. Watt SL, Lunstrum GP, McDonough AM, Keene DR, Burgeson RE, Morris NP. Characterization of collagen types XII and XIV from fetal bovine cartilage. J Biol Chem 1992;267:20093-9.
13. Goldring MB. The role of the chondrocyte in osteoarthritis. Arthritis Rheum 2000;43:1916-26.
14. Heinegård D, Oldberg A. Structure and biology of cartilage and bone matrix noncollagenous macromolecules. FASEB J 1989;3:2042-51.
15. Heinegård D, Saxne T, Lorenzo P. Noncollagenous proteins: glycoproteins and related molecules. In: Seibel MJ, Robins SP, Bilezekian JP, editors. Dynamics of bone and cartilage metabolism. New York: Academic Press; 1999. p. 59-69.
16. Knudson CB, Knudson W. Cartilage proteoglycans. Semin Cell Dev Biol 2001;12:69-78.
17. Alini M, Roughley PJ. Changes in leucine-rich repeat proteoglycans during maturation of the bovine growth plate. Matrix Biol 2001;19:805-13.
18. Homandberg GA. Potential regulation of cartilage metabolism in osteoarthritis by fibronectin fragments. Front Biosci 1999;4:D713-30.
19. Salminen H, Perälä M, Lorenzo P, Saxne T, Heinegård D, Säämiinen A-M, et al. Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthritis Rheum 2000;43:1742-8.
20. Kleemann-Fischer D, Kleemann GR, Engel D, Yates JR III, Wu JJ, Eyre DR. Molecular properties of matrilin-3 isolated from human growth cartilage. Arch Biochem Biophys 2001;387:209-15.
21. Klatt AR, Nitsche DP, Kobbe B, Morgelin M, Paulsson M, Wagener R. Molecular structure and tissue distribution of matrilin-3, a filament-forming extracellular matrix protein expressed during skeletal development. J Biol Chem 2000;275:3999-4006.
22. Tsuruha J, Masuko-Hongo K, Kato T, Sakata M, Nakamura H, Nishioka K. Implication of cartilage intermediate layer protein in cartilage destruction in subsets of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001;44:838-45.
23. Sekine T, Masuko-Hongo K, Matsui T, Asahara H, Takigawa M, Nishioka K, et al. Recognition of YKL-39, a human cartilage related protein, as a target antigen in patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:49-54.
24. Sakata M, Tsuruha JI, Masuko-Hongo K, Nakamura H, Matsui T, Sudo A, et al. Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2001;28:1492-5.
25. Langer F, Gross AE, West M, Urovitz EP. The immunogenicity of allograft knee joint transplants. Clin Orthop 1978;132:155-62.
26. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Leroux JY, Rosenberg LC, et al. Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. Arthritis Rheum 1998;41:1019-25.
27. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Webber C, Esdaile J, et al. Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 1998;25:1480-4.
28. Glant T, Csongor J, Szucs T. Immunopathologic role of proteoglycan antigens in rheumatoid joint disease. Scand J Immunol 1980;11:247-52.
29. Saxne T, Heinegård D, Wollheim FA, Pettersson H. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 1985;2:127-8.
30. Witter J, Roughley PJ, Webber C, Roberts N, Keystone E, Poole AR. The immunologic detection and characterization of cartilage proteoglycan degradation products in synovial fluids of patients with arthritis. Arthritis Rheum 1987;30:519-29.
31. Dayer E, Mathai L, Glant TT, Mikecz K, Poole AR. Cartilage proteoglycan-induced arthritis in BALB/c mice: antibodies that recognize human and mouse cartilage proteoglycan and can cause depletion of cartilage proteoglycan with little or no synovitis. Arthritis Rheum 1990;33:1394-405.
32. Mikecz K, Glant TT, Buzas E, Poole AR. Proteoglycan-induced polyarthritis and spondylitis adoptively transferred to naive (non-immunized) BALB/c mice. Arthritis Rheum 1990;33:866-76.
33. Glant TT, Bardos T, Vermes C, Chandrasekaran R, Valdez JC, Otto JM, et al. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum 2001;44:682-92.
34. Yoo JU, Kresina TF, Malemud CJ, Goldberg VM. Epitopes of proteoglycans eliciting an anti-proteoglycan response in chronic immune synovitis. Proc Natl Acad Sci U S A 1987;84:832-6.
35. Glant TT, Fulop C, Cs-Szabó G, Buzas E, Ragasa D, Mikecz K. Mapping of arthritogenic/autoimmune epitopes of cartilage aggrecans in proteoglycan-induced arthritis. Scand J Rheumatol Suppl 1995;101:43-9.
36. Glant TT, Cs-Szabó G, Nagase H, Jacobs JJ, Mikecz K. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum 1998;41:1007-18.
37. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998;153:1283-91.
38. Keiser H, Sandson JI. Immunodiffusion and gel-electrophoretic studies of human articular cartilage proteoglycan. Arthritis Rheum 1974;17:219-28.
39. Van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988;331:171-3.
40. Van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 1985;82:5117-20.
41. Andriopoulos N, Mestecky J, Wright G, Miller E. Characterization of antibodies to the native human collagens and to their component alpha chains in the sera and joint fluids of patients with rheumatoid arthritis. Immunochemistry 1976;13:709-12.
42. Beard HK, Ryvar R, Skingle J, Greenbury CL. Anti-collagen antibodies in sera from rheumatoid arthritis patients. J Clin Pathol 1980;33:1077-81.
43. Morgan K, Clague R, Collins I, Ayad S, Phinn S, Holt P. Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis 1987;46:902-7.
44. Charriere G, Hartmann DJ, Vignon E, Ronziere M, Herbage D, Ville G. Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum 1988;31:325-32.
45. Tarkowski A, Klareskog L, Carlsten H, Herberts P, Koopman W. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989;32:1087-92.
46. Terato K, Shimozuru Y, Katayama K, Takemitsu Y, Yamashita I, Miyatsu M, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 1990;33:1493-1500.
47. Terato K, DeArmey D, Griffiths M, Cremer MA. The mechanism of autoantibody formation to cartilage in rheumatoid arthritis: possible cross-reaction of antibodies to dietary collagens with autologous type II collagen. Clin Immunol Immunopathol 1996;79:142-54.
48. Kraetsch HG, Unger C, Wernhoff P, Schneider C, Kalden JR, Holmdahl R, et al. Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur J Immunol 2001;31:1666-73.
49. Cook A, Rowley M, Mackay I, Gough A, Emery P. Antibodies to type II collagen in early rheumatoid arthritis: correlation with disease progression. Arthritis Rheum 1996;39:1720-7.
50. Londei M, Savill C, Verhoef A, Brennan F, Leech Z, Duance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA 1989;86:636-40.
51. Trentham D, Townes A, Kang A. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
52. Courtenay J, Dallman M, Dayan A, Martin A, Mosedale B. Immunization against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
53. Wooley P, Luthra H, Stuart J, David C. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 1981;154:688-700.
54. Hart BA, Bakker N, Jonker M, Bontrop R. Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen. Eur J Immunol 1993;23:1588-94.
55. Shimozuru Y, Yamane S, Fujimoto K, Terao K, Honjo S, Nagai Y, et al. Collagen-induced arthritis in nonhuman primates: multiple epitopes of type II collagen can induce autoimmune-mediated arthritis in outbred cynomolgus monkeys. Arthritis Rheum 1998;41:507-14.
56. Steffen C, Timpl R, Wolff I. Immunogenicity and specificity of collagen. V. Demonstration of three different antigenic determinants on calf collagen. Immunology 1968;15:135-44.
57. Timpl R, Wolff I, Furthmayr H, Steffen C. Immunogenicity and specificity of collagen. VI. Separation of antibody fractions with restricted specificity from anti-collagen sera using an immunoadsorbent technique. Immunology 1968;15:145-51.
58. Myers LK, Seyer JM, Stuart JM, Terato K, David CS, Kang AH. T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol 1993;151:500-5.
59. Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH. Collagen-induced arthritis in B10.RIII mice (H-2r): identification of an arthritogenic T-cell determinant. Immunology 1995;84:509-13.
60. Terato K, Hasty KA, Cremer MA, Stuart JM, Townes AS, Kang AH. Collagen-induced arthritis in mice: localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med 1985;162:637-46.
61. Kim H-Y, Kim W-U, Cho M-L, Lee SK, Youn J, Kim S-I, et al. Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum 1999;42:2085-93.
62. Chu CQ, Londei M. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis. J Autoimmun 1999;12:35-42.
63. Cremer M, Ye X, Terato K, Owens S, Seyer J, Kang A. Type XI collagen-induced arthritis in the Lewis rat: characterization of cellular and humoral responses to native types XI, V and II collagen and constituent a-chains. J Immunol 1994;155:824-32.
64. Cremer M, Griffiths M, Terato K, Kang A. Type XI and II collagen-induced arthritis in rats: characterization of inbred rats for arthritis-susceptibility and immune-responsiveness to types XI and II collagen. Autoimmunity 1994;20:153-161.
65. Boissier M-C, Chiocchia G, Ronziere M-C, Herbage D, Fournier C. Arthritogenicity of minor cartilage collagens (types IX and XI) in mice. Arthritis Rheum 1990;33:1-8.
66. Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum 2000;29:252-65.
67. Glant T, Mikecz K. Antigenic profiles of human, bovine and canine articular chondrocytes. Cell Tissue Res 1986;244:359-69.
68. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 1994;84:3261-82.
69. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
70. Mitchell NS, Shepard N. Changes in proteoglycan and collagen in cartilage in rheumatoid arthritis. J Bone Joint Surg Am 1978;60:342-8.
71. Alsalameh S, Jahn B, Krause A, Kalden JR, Burmester GR. Antigenicity and accessory cell function of human articular chondrocytes. J Rheumatol 1991;18:414-21.
72. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997;24:365-71.
73. Ishii H, Yoshino S, Nakamura H, Tsuruha J, Kato T, Nishioka K. Immunophenotyping of synovial activated T cells and expression of Th1/Th2 cytokines in osteoarthritis [abstract]. Arthritis Rheum 1999;42 Suppl 9:S254.
74. Nakamura H, Yoshino S, Kato T, Tsuruha J, Nishioka K. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthritis Cartilage 1999;7:401-2.
75. Sakkas LI, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P, et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol 1998;5:430-7.
76. Champion BR, Poole AR. Immunity to homologous type III collagen after partial meniscectomy and sham surgery in rabbits. Arthritis Rheum 1982;25:274-87.
77. Alsalameh S, Mollenhauer J, Hain N, Stock K-P, Kalden JR, Burmester GR. Cellular immune response toward human articular chondrocytes: T cell reactivities against chondrocyte and fibroblast membranes in destructive joint diseases. Arthritis Rheum 1990;33:1477-86.
78. Guerassimov A, Zhang Y, Cartman A, Rosenberg LC, Esdaile J, Fitzcharles MA, et al. Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis. Arthritis Rheum 1999;42:527-33.
79. Stuart JM, Postlethwaite AE, Townes AS, Kang AH. Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med 1980;69:13-8.
80. Yuan GH, Xiang Y, Shi GY. Detection of serum anti-chondrocytes in patients with osteoarthritis. Chin J Rheumatol (Chinese) 1997;1:15-7.
81. Mollenhauer J, von der Mark K, Burmester G, Gluckert K, Lutjen-Drecolle E, Brune K. Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol 1988;15:1811-7.
82. Austin AK, Hobbs RN, Anderson JC, Butler RC, Ashton BA. Humoral immunity to link protein in patients with inflammatory joint disease, osteoarthritis, and in non-arthritic controls. Ann Rheum Dis 1988;47:886-92.
83. Niebauer GW, Wolf B, Yarmush M, Richardson DW. Evaluation of immune complexes and collagen type-specific antibodies in sera and synovial fluids of horses with secondary osteoarthritis. Am J Vet Res 1988;49:1223-7.
84. De Rooster H, Cox E, van Bree H. Prevalence and relevance of antibodies to type-I and -II collagen in synovial fluid of dogs with cranial cruciate ligament damage. Am J Vet Res 2000;61:1456-61.
85. Cooke TD. Significance of immune complex deposits in osteoarthritic cartilage. J Rheumatol 1987;14:77-9.
86. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
87. Takagi T, Jasin HE. Interactions between anticollagen antibodies and chondrocytes. Arthritis Rheum 1992;35:224-30.
88. Nakagawa K, Sakiyama H, Tsuchida T, Yamaguchi K, Toyoguchi T, Masuda R, et al. Complement C1s activation in degenerating articular cartilage of rheumatoid arthritis patients: immunohistochemical studies with an active form specific antibody. Ann Rheum Dis 1999;58:175-81.
89. Cooke TD, Bennett EL, Ohno O. The deposition of immunoglobulins and complement in osteoarthritic cartilage. Int Orthop 1980;4:211-7.
90. Bradley K, North J, Saunders D, Schwaeble W, Jeziorska M, Woolley DE, et al. Synthesis of classical pathway complement components by chondrocytes. Immunology 1996;88:648-56.
91. Onuma H, Masuko-Hongo K, Yuan GH, Sakata M, Nakamura H, Kato T, et al. Expression of the anaphylatoxin receptor C5aR (CD88) by human articular chondrocytes. Rheumatol Int 2002; 52-5.
92. Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 2002;3:360-5.
93. Goldring MB. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000;2:459-65.
94. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.
95. Malemud CJ, Goldberg VM. Future directions for research and treatment of osteoarthritis. Front Biosci 1999;4:D762-71.
96. Poole AR. An introduction to the pathophysiology of osteoarthritis. Front Biosci 1999;4:D662-70.
97. Van der Kraan PM, van den Berg WB. Anabolic and destructive mediators in osteoarthritis. Curr Opin Clin Nutr Metab Care 2000;3:205-11.
98. Westacott CI, Sharif M. Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 1996;25:254-72.
99. Moos V, Fickert S, Muller B, Weber U, Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 1999;26:870-9.
100. Chikanza I, Fernandes L. Novel strategies for the treatment of osteoarthritis. Expert Opin Investig Drugs 2000;9:1499-510.
101. Martel-Pelletier J, Alaaeddine N, Pelletier J-P. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999;4:D694-703.
102. Van den Berg WB. The role of cytokines and growth factors in cartilage destruction in osteoarthritis and rheumatoid arthritis. Z Rheumatol 1999;58:136-41.
103. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998;41:2165-74.
104. Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2000;44:585-94.
105. Gouze JN, Bordji K, Gulberti S, Terlain B, Netter P, Magdalou J, et al. Interleukin-1β down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: influence of glucosamine on interleukin-1β-mediated effects in rat chondrocytes. Arthritis Rheum 2001; 44:351-60.
106. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor KB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000;43:801-11.
107. Attur MG, Patel RN, Abramson SB, Amin AR. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage. Arthritis Rheum 1997;40:1050-3.
108. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
109. Godessart N, Kunkel SL. Chemokines in autoimmune disease. Curr Opin Immunol 2001;13:670-5.
110. Koch AE, Kunkel SL, Shah MR, Fu R, Mazarakis DD, Haines GK, et al. Macrophage inflammatory protein-1β: a C-C chemokine in osteoarthritis. Clin Immunol Immunopathol 1995;77:307-14.
111. Kaneko S, Satoh T, Chiba J, Ju C, Inoue K, Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000;6:71-9.
112. Lisignoli G, Toneguzzi S, Pozzi C, Piacentini A, Grassi F, Ferruzzi A, et al. Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis and rheumatoid arthritis patients. Clin Exp Immunol 1999;116:371-8.
113. Lisignoli G, Toneguzzi S, Pozzi C, Piacentini A, Riccio M, Ferruzzi A, et al. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1999;26:791-9.
114. Yuan GH, Masuko-Hongo K, Nishioka K. Role of chemokines/chemokine receptor systems in cartilage degradation. Drug News Perspectives 2001;14:591-600.
115. Yuan GH, Masuko-Hongo K, Sakata M, Tsuruha J, Onuma H, Nakamura H, et al. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 2001;44:1056-70.
116. Pulsatelli L, Dolzani P, Piacentini A, Silvestri T, Ruggeri R, Gualtieri G, et al. Chemokine production by human chondrocytes. J Rheumatol 1999;26:1992-2001.
117. Borzi RM, Mazzetti I, Macor S, Silvestri T, Bassi A, Cattini L, et al. Flow cytometric analysis of intracellular chemokines in chondrocytes in vivo: constitutive expression and enhancement in osteoarthritis and rheumatoid arthritis. FEBS Lett 1999;455:238-42.
118. Alaaeddine N, Olee T, Hashimoto S, Creighton-Achermann L, Lotz M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001;44:1633-43.
119. Borzi RM, Mazzetti I, Cattini L, Uguccioni M, Baggiolini M, Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000;43:1734-41.
120. McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002;110:651-8.
121. Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001;108:15-23.